These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 9823313
1. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Cancer Res; 1998 Nov 15; 58(22):5071-4. PubMed ID: 9823313 [Abstract] [Full Text] [Related]
2. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Clin Cancer Res; 2000 Jan 15; 6(1):127-34. PubMed ID: 10656440 [Abstract] [Full Text] [Related]
3. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Lu CD, Altieri DC, Tanigawa N. Cancer Res; 1998 May 01; 58(9):1808-12. PubMed ID: 9581817 [Abstract] [Full Text] [Related]
4. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. Langlois NE, Lamb J, Eremin O, Heys SD. J Pathol; 1997 Aug 01; 182(4):392-7. PubMed ID: 9306959 [Abstract] [Full Text] [Related]
5. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M, Löhrs U. Cancer; 1996 Jan 15; 77(2):255-64. PubMed ID: 8625232 [Abstract] [Full Text] [Related]
6. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC. Clin Cancer Res; 1999 Jul 15; 5(7):1793-804. PubMed ID: 10430084 [Abstract] [Full Text] [Related]
7. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C, Liu FF. Clin Cancer Res; 2006 Oct 01; 12(19):5726-32. PubMed ID: 17020977 [Abstract] [Full Text] [Related]
8. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI. Anticancer Res; 2001 Oct 01; 21(1A):253-9. PubMed ID: 11299743 [Abstract] [Full Text] [Related]
9. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Zhang Y, Huang D, Yu G. Acta Otolaryngol; 2005 Dec 01; 125(12):1345-50. PubMed ID: 16303685 [Abstract] [Full Text] [Related]
10. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K, Tominaga S, Hiroi S, Kawai T, Aida S, Kasamatsu H, Aurues T, Hayashi T, Ikeda T. Virchows Arch; 2002 Dec 01; 441(6):559-63. PubMed ID: 12461612 [Abstract] [Full Text] [Related]
11. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma. Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E, Guo X. Laryngoscope; 2006 Jan 01; 116(1):126-30. PubMed ID: 16481824 [Abstract] [Full Text] [Related]
12. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Krajewska M, Kim H, Kim C, Kang H, Welsh K, Matsuzawa S, Tsukamoto M, Thomas RG, Assa-Munt N, Piao Z, Suzuki K, Perucho M, Krajewski S, Reed JC. Clin Cancer Res; 2005 Aug 01; 11(15):5451-61. PubMed ID: 16061861 [Abstract] [Full Text] [Related]
14. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Agui T, McConkey DJ, Tanigawa N. Anticancer Res; 2002 Aug 01; 22(3):1769-76. PubMed ID: 12168867 [Abstract] [Full Text] [Related]
15. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract. Jeong IG, Kim SH, Jeon HG, Kim BH, Moon KC, Lee SE, Lee E. Hum Pathol; 2009 May 01; 40(5):668-77. PubMed ID: 19157504 [Abstract] [Full Text] [Related]
16. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2. Mainou-Fowler T, Overman LM, Dignum H, Wood K, Crosier S, Angus B, Proctor SJ, Anderson JJ. Int J Oncol; 2008 Jan 01; 32(1):59-68. PubMed ID: 18097543 [Abstract] [Full Text] [Related]
17. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Sinicrope FA, Hart J, Michelassi F, Lee JJ. Clin Cancer Res; 1995 Oct 01; 1(10):1103-10. PubMed ID: 9815900 [Abstract] [Full Text] [Related]
18. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Zhang GJ, Kimijima I, Abe R, Watanabe T, Kanno M, Hara K, Tsuchiya A. Anticancer Res; 1998 Oct 01; 18(3B):1989-98. PubMed ID: 9677455 [Abstract] [Full Text] [Related]
19. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma. Tucci MG, Lucarini G, Giangiacomi M, Zizzi A, Criante P, Ricotti G, Biagini G. J Eur Acad Dermatol Venereol; 2006 Nov 01; 20(10):1220-5. PubMed ID: 17062035 [Abstract] [Full Text] [Related]
20. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Sharma H, Sen S, Mathur M, Bahadur S, Singh N. Head Neck; 2004 Aug 01; 26(8):733-40. PubMed ID: 15287041 [Abstract] [Full Text] [Related] Page: [Next] [New Search]